BRMS1L confers anticancer activity in non-small cell lung cancer by transcriptionally inducing a redox imbalance in the GPX2-ROS pathway
Article in Translational Oncology (January 2024)
The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.
Article in Translational Oncology (January 2024)
Article in Experimental and Therapeutic Medicine (September 2023)
Article in Thoracic Cancer (July 2023)